How to Get Amvuttra (Vutrisiran) Covered by Aetna CVS Health in Michigan: Complete Authorization and Appeal Guide

Answer Box: Getting Amvuttra Covered by Aetna CVS Health in Michigan

Amvuttra (vutrisiran) requires prior authorization from Aetna CVS Health in Michigan. The fastest path to approval: (1) Submit complete clinical documentation including TTR genetic testing, specialist evaluation, and baseline neuropathy scores through Aetna's provider portal, (2) Allow 24-48 hours for determination with complete records, (3) If denied, file internal appeal within 60 days, then external review with Michigan DIFS within 127 days. Start today: Contact your neurologist to gather TTR mutation documentation and baseline polyneuropathy disability scores.


Table of Contents


Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required Must get approval before treatment Aetna Precertification List
Specialist Evaluation Neurologist consultation required Clinical policy bulletins
TTR Genetic Testing Confirmed pathogenic TTR mutation Genetic testing guidelines
Baseline Documentation PND score ≤ IIIb (not wheelchair-bound) CareSource policy example
Age Requirement 18 years or older FDA label requirements
Dosing Limit 25mg every 3 months, 1 syringe per 84 days Quantity limit policies

Step-by-Step: Fastest Path to Approval

1. Gather Essential Documentation (Patient + Clinic)

Timeline: 1-2 weeks
Who does it: Patient coordinates with neurologist
Documents needed:

  • TTR genetic test results showing pathogenic mutation
  • Neurologist consultation notes
  • Baseline polyneuropathy disability (PND) score
  • Documentation that PND score is IIIb or better

2. Submit Prior Authorization Request (Clinic)

Timeline: Same day
Who does it: Prescribing physician or staff
How to submit: Aetna provider portal or call 1-888-632-3862
Required forms: Complete clinical documentation package

3. Await Initial Determination (Aetna)

Timeline: 24-48 hours with complete documentation
Expected outcome: Over 95% of complete PA requests approved within 24 hours
What happens: Aetna reviews against clinical criteria

4. If Approved: Begin Treatment

Next steps: Coordinate with CVS Specialty Pharmacy for delivery and administration scheduling

5. If Denied: File Internal Appeal (Patient/Clinic)

Timeline: Must file within 60 days of denial
Who does it: Patient or authorized representative
How to submit: Written appeal with additional clinical evidence

6. If Still Denied: External Review with Michigan DIFS

Timeline: File within 127 days of final internal denial
Who does it: Patient
How to submit: Michigan DIFS External Review form or call 877-999-6442

7. Expedited Appeals (If Urgent)

When to use: Delay would seriously jeopardize health
Timeline: 72-hour decision
Requirement: Physician letter certifying medical urgency


Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Documents Needed
Missing TTR genetic confirmation Submit pathogenic TTR variant test results Validated genetic testing from accredited lab
Lack of specialist evaluation Provide neurologist consultation Complete neurology assessment with hATTR-PN diagnosis
Insufficient baseline documentation Submit PND scores and functional status Baseline neuropathy measures showing PND ≤ IIIb
"Experimental/investigational" Cite FDA approval and clinical trials FDA label and HELIOS-B trial data
Step therapy not completed Document contraindications to alternatives Evidence of intolerance or medical reasons avoiding other TTR therapies

Appeals Playbook for Michigan

Internal Appeals with Aetna CVS Health

  • Deadline: 60 days from denial notice
  • How to file: Written request with additional clinical evidence
  • Timeline: 30 days for standard review, 72 hours for urgent
  • Required: Address each denial reason point-by-point

External Review with Michigan DIFS

  • Deadline: 127 days from final internal denial
  • How to file: Online form or call 877-999-6442
  • Timeline: 56-84 days for standard, 72 hours for expedited
  • Cost: No fee to patient
  • Decision: Binding on Aetna if overturned
Tip: Michigan's 127-day deadline is longer than the federal 120-day minimum, giving you extra time to prepare a strong external review.

Expedited Appeals Process

When to request: Physician certifies delay would seriously harm patient health
Required documentation:

  • Physician letter stating medical urgency
  • Clinical evidence of time-sensitive need
  • Complete medical records supporting urgency

Clinician Corner: Medical Necessity Letter

Essential Components for Amvuttra Authorization

Patient Demographics & Diagnosis

  • Confirmed hATTR amyloidosis with polyneuropathy
  • TTR genetic testing showing pathogenic mutation
  • ICD-10 codes: E85.1 (neuropathic heredofamilial amyloidosis)

Clinical Rationale

  • Baseline polyneuropathy disability score ≤ IIIb
  • Progressive sensorimotor and/or autonomic neuropathy
  • Functional impairment requiring treatment intervention

Treatment History

  • Document any prior TTR-targeting therapies tried
  • Note contraindications or intolerance to alternatives
  • Explain why Amvuttra is most appropriate choice

Evidence Base

  • Reference FDA approval for hATTR-PN indication
  • Cite APOLLO Phase 3 trial efficacy data
  • Include safety profile compared to alternatives

Monitoring Plan

  • Quarterly administration schedule
  • Functional outcome measures for renewal
  • Vitamin A monitoring as clinically indicated

Key Guidelines to Reference


Patient Scripts & Templates

Calling Aetna CVS Health About Your Prior Authorization

"Hello, I'm calling about a prior authorization request for Amvuttra, spelled A-M-V-U-T-T-R-A, for hereditary TTR amyloidosis. My member ID is [ID number]. Can you tell me the status of this request and what additional information might be needed?"

Key questions to ask:

  • What's the current status of my PA request?
  • What specific clinical criteria are required?
  • Is there a case number I can reference?
  • Who should my doctor contact if more information is needed?

Email Template for Clinic Staff

Subject: Urgent - Additional Documentation Needed for Amvuttra PA

"We need to gather the following documents for [Patient Name]'s Amvuttra prior authorization with Aetna CVS Health:

  1. TTR genetic testing results
  2. Baseline PND score documentation
  3. Neurologist consultation notes
  4. Any prior TTR therapy trial records

Please prioritize this request as the patient's treatment is time-sensitive. Let me know if you need help locating any of these documents."


Costs & Savings Options

Manufacturer Support Programs

  • Alnylam Assist: Patient support program offering copay assistance and insurance navigation
  • Website: alnylamassist.com
  • Eligibility: Varies by insurance type and income

Foundation Grants

  • Patient Access Network Foundation: Provides copay assistance for rare diseases
  • National Organization for Rare Disorders: Emergency financial assistance
  • HealthWell Foundation: Copay and premium assistance programs

Michigan-Specific Resources

  • Michigan Department of Health and Human Services: Medicaid coverage information
  • Michigan Rare Disease Advisory Council: Patient advocacy and resources
Note: List price for Amvuttra is approximately $119,351 per dose (quarterly), making patient assistance programs crucial for most families.

FAQ: Your Top Questions Answered

How long does Aetna CVS Health prior authorization take in Michigan?

Over 95% of complete PA requests are approved within 24 hours when all required documentation is submitted. Incomplete requests may take 30-45 days.

What if Amvuttra is non-formulary on my plan?

You can request a formulary exception by demonstrating medical necessity and showing that formulary alternatives are inappropriate or have been tried and failed.

Can I request an expedited appeal if my condition is worsening?

Yes, Michigan allows expedited external appeals within 72 hours if your physician certifies that delay would seriously jeopardize your health.

Does step therapy apply if I haven't tried other TTR therapies?

Aetna may require documentation of why other TTR-targeting therapies (like tafamidis) are inappropriate rather than requiring you to fail them first, especially if there are medical contraindications.

What happens if my external review is denied?

You have 60 days to seek judicial review in Michigan circuit court, though this step is rarely necessary as external reviews have high overturn rates for medically necessary treatments.

How often do I need to renew my Amvuttra authorization?

Initial approvals are typically for 9 months, with 12-month renewals if you show improvement or stabilization in neuropathy measures, gait, nutritional status, or quality of life.

Can my doctor handle the appeal process for me?

Yes, your physician or another authorized representative can file appeals on your behalf with your written consent. This is often more effective as they can provide clinical context.

What if I move from Michigan to another state?

Your external review rights will change based on your new state's laws. Most states have similar processes, but timelines and procedures vary.


At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by drafting evidence-backed authorization requests that align with payer-specific requirements. Our platform identifies denial patterns and creates targeted rebuttals using the right clinical evidence, procedural requirements, and payer workflows to maximize approval chances.

When facing complex prior authorizations like Amvuttra, having the right documentation strategy can make the difference between approval and lengthy appeals. Counterforce Health streamlines this process by automatically generating compliant submissions that meet each payer's specific criteria while tracking deadlines and required attachments.


Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual plan and circumstances. Always consult with your healthcare provider and insurance plan for specific guidance regarding your situation. For questions about Michigan insurance regulations, contact the Michigan Department of Insurance and Financial Services at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.